Proteomic biomarkers and pathway analysis for progression to heart failure in three epidemiological representative cohorts.

Fiche publication

Date publication

octobre 2024

Journal

European journal of heart failure

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick

Tous les auteurs :
Dieden A, Girerd N, Ottosson F, Molvin J, Pareek M, Melander O, Bachus E, Råstam L, Lindblad U, Daka B, Leósdóttir M, Nilsson PM, Olsen MH, Clark AL, Cleland JGF, Delles C, González A, Lamiral Z, Duarte K, Rossignol P, Zannad F, Gudmundsson P, Jujić A, Magnusson M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39466935

Résumé

Biomarkers associated with asymptomatic ventricular dysfunction might improve risk stratification and identify pathways leading to heart failure (HF). We explored the association between proteomic biomarkers and left ventricular hypertrophy (LVH), diastolic dysfunction (DD) and incident HF in three population-based cohorts.